Bal Pharma Limited Stock: price and insider trades · India
No insider purchase over the last 90 days. The latest, by SHAILESH SIROYA, was filed 13 Apr 2022.
Bal Pharma Limited: what insiders have been doing
Bal Pharma Limited, classified in the Health Care sector, is a listed company. Its insiders report their share dealings to SEBI (PIT + SAST). The past year has been quiet: not a single insider filing for Bal Pharma Limited. The previous disclosure was published on 13 April 2022.
For comparison within the same sector, see the insider buying recorded at Relmada Therapeutics, Inc. and MAIA Biotechnology, Inc. Every figure here comes from the filings published by SEBI (PIT + SAST) and describes the past, not future prices; it is not investment advice.
Since the insiders bought
- -37.5%Entry ₹114.55 · Close at T+365 ₹71.60
- -13.3%Entry ₹102.30 · Close at T+365 ₹88.70
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2026FY ended March 2026 · cache
- 750,000 shares@ ₹50.00100.0% of flowEquity SharesSEBI:620ffbe1381314cef64b742e0cfc96a4e6493462Canonical exit: 12 Jul 2022 (T+90)
- 400,000 shares@ ₹92.450299.2% of flowEquity SharesSEBI:5227c13838f4f22691e2aeda69eb2fe3b83d77c9Canonical exit: 21 Feb 2022 (T+90)
- 300,900 shares@ ₹1.000.8% of flowEquity SharesSEBI:c65f6d34ee8d0fd3c0b875aeb0b3601839bc075dCanonical exit: 25 Nov 2021 (T+90)
3 of 3 declarations
About Bal Pharma Limited
Bal Pharma Limited is a company focused on the health and pharmaceutical sector, providing a range of pharmaceutical products. It is listed on the XBOM.
